Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiversified Energy Regulatory News (DEC)

Share Price Information for Diversified Energy (DEC)

Share Price is delayed by 15 minutes
Get Live Data
1,046.00    0.00 (0.00%)
Bid:
1,042.00
Ask:
1,044.00
Spread: 2.00 (0.192%)
Market Cap: £756.50m
DEC Live PriceLast checked at - London Stock Exchange

Intraday Diversified Energy Share Chart

Pre-Stabilisation Notice

20 Feb 2025 07:01

RNS Number : 8434X
Diversified Energy Company PLC
20 February 2025
 

 

Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement.

 

 

February 20, 2025

 

Diversified Energy Company PLC

("Diversified" or the "Company")

Pre-Stabilisation Notice

 

 

Citigroup Global Markets Inc (Contact: Gabriel Xia +1 212-723-3224) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) and the rules of the Financial Conduct Authority.

 

The securities:

Issuer:

Diversified Energy Company PLC (the "Company")

Securities:

Ordinary Shares with a par value of £0.20 each

ISIN:

GB00BQHP5P93

Offering size:

8,500,000 Ordinary Shares (excluding the over-allotment option)

Description:

An underwritten public offering in the United States of up to 8,500,000 ordinary shares

Offer price:

 US$14.50

Stabilisation:

Stabilising manager:

Citigroup Global Markets Inc, 388 Greenwich Street, New York, New York 10013, United States of America 

Stabilisation period expected to start on:

20 February 2025

Stabilisation period expected to end no later than:

22 March 2025 (close of business), being the date which is 30 calendar days from the beginning of the stabilisation period

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 850,000 Ordinary Shares (representing a maximum of 10% of the total number of Ordinary Shares comprised in the offer).

Stabilisation trading venue:

All Stabilisation activity will occur in the United States

Over-allotment Option:

Terms:

In connection with the offer, the Stabilising Manager or any of its agents may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares or effect other stabilisation transactions with a view to supporting the market price of the Ordinary Shares at a higher level than that which might otherwise prevail in the open market. The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of adequate public disclosure of the final price of the securities and ends no later than 30 calendar days after the date of allotment. However, there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. Except as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the offer.

 

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any over-allotments and/or from sales of Ordinary Shares effected by it during the stabilising period, the Company has granted the Stabilising Manager an option (the "Over-allotment Option"), pursuant to which the Stabilising Manager may subscribe or procure subscribers for up to 850,000 additional Ordinary Shares (representing a maximum of 10% of the total number of Ordinary Shares comprised in the offer (the "Over-allotment Shares") at the offer price. The Over-allotment Option is exercisable in whole or in part upon notice by the Stabilising Manager, at any time during the stabilisation period.

Duration:

The Over-allotment Option may be exercised in full or in part at any time during the stabilisation period.

 

Important Notice to UK and EU Investors

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Company in any jurisdiction in which such an offer or solicitation is unlawful. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

 

This announcement is addressed to and directed at persons who: (A) if in Member States of the European Economic Area ("Member States"), are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 who are: (i) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (ii) high net worth bodies corporate, unincorporated associations and partnerships or the trustees of high value trusts falling within Article 49(2)(a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) together being "Relevant Persons"). This announcement must not be acted or relied on: (i) in the United Kingdom, by persons who are not Relevant Persons; and (ii) in any Member State by persons who are not Qualified Investors. Any investment activity to which this announcement relates: (i) in the United Kingdom is available only to, and may be engaged only with, Relevant Persons; and (ii) in any Member State is available only to, and may be engaged only with, Qualified Investors.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STASELSDSEISEIE
Date   Source Headline
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSDiversified Announces Increase in Borrowing Base
25th Sep 20235:01 pmRNSReplacement: Transaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:01 amRNSQ1 2023 Dividend Exchange Rate
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:01 amRNSDiversified Announces Executive Leadership Changes
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSDiversified Announces Upcoming Investor Engagement
11th Sep 20237:00 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 20237:01 amRNSInterim Results for the 6 Months Ended 30 June '23
1st Sep 20237:00 amRNSSecond Quarter Dividend Announcement
30th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20237:00 amRNSTotal Voting Rights
17th Jul 20237:00 amRNSStrategic Monetization of Assets
10th Jul 20237:01 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTotal Voting Rights
3rd Jul 20237:00 amRNSVesting Restricted Stock & PDMR Share Dealing
28th Jun 20237:05 amRNSStrategic Divestiture of Non-Operated Assets
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSDetails of Share Buyback Programme
16th Jun 20237:00 amRNSQ4 2022 Dividend Exchange Rate
15th Jun 20237:00 amRNSDiversified Announces Upcoming Investor Engagement
6th Jun 20237:00 amRNSHolding(s) in Company
1st Jun 20237:01 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20237:03 amRNSDirector/PDMR Shareholding
31st May 20237:02 amRNSDirector/PDMR Shareholding
31st May 20237:01 amRNSTotal Voting Rights
31st May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSUnanimous Approval of Borrowing Base
17th May 20237:00 amRNSConfirmation of Announced Dividend Timelines
9th May 20237:01 amRNSFirst Quarter 2023 Trading Statement
9th May 20237:00 amRNSFirst Quarter Dividend Announcement
3rd May 20237:05 amRNSNotice of Trading Statement Timing
3rd May 20237:00 amRNSResults of Annual General Meeting
19th Apr 20237:00 amRNSHolding(s) in Company
11th Apr 20237:00 amRNS2022 Sustainability Report Published
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.